Home Biosimilar Antibodies Stem Cells & Wnt Notch inhibitor Brontictuzumab (Anti-NOTCH1)
For research use only. Not for use in humans.

Brontictuzumab (Anti-NOTCH1)

Synonyms: OMP 52M51

Brontictuzumab (Anti-NOTCH1) is a monoclonal antibody that targets Notch1 signal. It inhibits tumor cell proliferation and can be used in the research of leukemia and lymphoma. MW :150 KD.

Brontictuzumab (Anti-NOTCH1)

Quality Control

Specificity

Name Citation Notch Others
RO4929097 (RG-4733) 123 γ secretase,Aβ40
Semagacestat (LY450139) 22 Aβ42,Aβ38,Aβ40
DBZ (Dibenzazepine) 40 γ secretase
LY411575 42 γ secretase
IMR-1A 0
IMR-1 7
FLI-06 13
Crenigacestat (LY3039478) 25
DAPT 398 Aβ
Limantrafin (CB-103) 4
Compound E 0 γ-secretase
Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Mechanism of Action

Description
Brontictuzumab (Anti-NOTCH1) is a monoclonal antibody that targets Notch1 signal. It inhibits tumor cell proliferation and can be used in the research of leukemia and lymphoma. MW :150 KD.
References

Product Details

CAS No. 1447814-75-6
Molecular Weight 150
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.